Kyverna Therapeutics, Inc. (KYTX) stock
KYTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$4.48−0.22 (-4.68%)
Close on Nov 18, 2026Market cap $277.06MP/E –Yield –
Kyverna Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Kyverna Therapeutics's market cap was $315.24M on Nov 11, 2026, against $335.90M a year earlier. Over the last 3 years it ranged from $18.93M to $540.23M, with a median of $315.24M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $315.24M | -23.4% |
| 2025 | Dec 31, 2025 | $411.66M | +155.0% |
| 2024 | Dec 31, 2024 | $161.45M | – |
See a number that looks wrong?